arginyl-glycyl-aspartic acid has been researched along with Astrocytoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alemany, R; Curiel, DT; Dirven, CM; Fueyo, J; Geoerger, B; Gerritsen, WR; Grill, J; Lamfers, ML; Pinedo, HM; Van Beusechem, VW; Van Den Berg, J; Vandertop, WP; Vassal, G | 1 |
Gladson, CL; Grammer, JR; Murphy-Ullrich, JE; Pearce, SF; Pijuan-Thompson, V; Silverstein, RL; Stewart, J; Tuszynski, GP | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and Astrocytoma
Article | Year |
---|---|
Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.
Topics: Adenoviridae; Adult; Aged; Animals; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Coxsackie and Adenovirus Receptor-Like Membrane Protein; Female; Glioblastoma; Humans; Integrin alphaVbeta3; Integrins; Male; Mice; Mice, Nude; Middle Aged; Oligopeptides; Receptors, Virus; Receptors, Vitronectin; Spheroids, Cellular; Tumor Cells, Cultured; Virus Replication; Xenograft Model Antitumor Assays | 2002 |
Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1.
Topics: Astrocytes; Astrocytoma; Brain; CD36 Antigens; Cell Adhesion; Cell Differentiation; Chondroitin ABC Lyase; Chondroitin Sulfates; Cytoskeleton; Endothelium; Ganglioneuroblastoma; Ganglioneuroma; Glioblastoma; Heparin; Humans; Integrin alpha3beta1; Integrins; Neuroblastoma; Neurons; Oligopeptides; Peptide Fragments; Polysaccharide-Lyases; Receptors, Fibronectin; Recombinant Proteins; Thrombospondin 1; Tretinoin; Tumor Cells, Cultured | 1999 |